{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:18:46Z","timestamp":1759796326628,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.prp.2022.154170","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T13:18:07Z","timestamp":1665667087000},"page":"154170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Different expression of DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN and EP300 genes in lymphomagenesis of low vs. high grade lymphoma"],"prefix":"10.1016","volume":"239","author":[{"given":"Katarina Horvat","family":"Pavlov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanja","family":"Tadi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela Ba\u0161i\u0107","family":"Palkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biljana","family":"Sasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nives","family":"Magdi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matea Zajc","family":"Petranovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Klasi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana","family":"Han\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Gr\u0161kovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Matuli\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slavko","family":"Ga\u0161parov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Dominis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Kora\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2022.154170_bib1","series-title":"Revised","article-title":"Classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.prp.2022.154170_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11605-015-2960-7","article-title":"Overexpression of CDT1 is a predictor of poor survival in patients with hepatocellular carcinoma","volume":"20","author":"Karavias","year":"2016","journal-title":"J. Gastrointest. Surg. . J. Soc. Surg. Aliment. Trac."},{"key":"10.1016\/j.prp.2022.154170_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-94-007-4572-8_5","article-title":"Cdt1 and geminin in DNA replication initiation","volume":"62","author":"Caillat","year":"2012","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.prp.2022.154170_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/path.1695","article-title":"DNA replication licensing in peripheral B-cell lymphoma","volume":"205","author":"Obermann","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2022.154170_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1266\/ggs.18-00026","article-title":"Regulation of MCM2-7 function","volume":"93","author":"Ishimi","year":"2018","journal-title":"Genes Genet. Syst."},{"key":"10.1016\/j.prp.2022.154170_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1471-2407-5-162","article-title":"Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis","volume":"5","author":"Obermann","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2022.154170_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-4598-13-29","article-title":"Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth","volume":"13","author":"Haery","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2022.154170_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.prp.2022.154170_bib9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/biom10040570","article-title":"Human PCNA structure, function and interactions","volume":"10","author":"Gonz\u00e1lez-Maga\u00f1a","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2022.154170_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tips.2014.02.004","article-title":"PCNA: a silent housekeeper or a potential therapeutic target?","volume":"35","author":"Wang","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.prp.2022.154170_bib11","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1073\/pnas.1920251117","article-title":"BioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA","volume":"117","author":"Lim","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.prp.2022.154170_bib12","first-page":"1944","article-title":"Drug resistance mechanisms in chronic lymphocytic leukemia","volume":"10","author":"Ribrag","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2022.154170_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/1568009620666200115162814","article-title":"Targeting proliferating cell nuclear antigen (PCNA) as an effective strategy to inhibit tumor cell proliferation","volume":"20","author":"Cardano","year":"2020","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.prp.2022.154170_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/10428199309148548","article-title":"Proliferating cell nuclear antigen (PCNA) expression in chronic lymphocytic leukemia (CLL)","volume":"10","author":"Del Giglio","year":"1993","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2022.154170_bib15","article-title":"Nuclear IGF1R Interact with PCNA to Preserve DNA Replication after DNA-Damage in a Variety of Human Cancers","volume":"15","author":"Yang","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2022.154170_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbrc.2019.07.039","article-title":"EZH2 Regulates PD-L1 Expression via HIF-1\u03b1 in Non-Small Cell Lung Cancer Cells","volume":"517","author":"Zhao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2022.154170_bib17","first-page":"85","article-title":"Immune modulatory functions of EZH2 in the tumor microenvironment: implications in cancer immunotherapy","volume":"7","author":"Wang","year":"2019","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.prp.2022.154170_bib18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The Polycomb Group Protein EZH2 Is Involved in Progression of Prostate Cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.prp.2022.154170_bib19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13045-019-0814-6","article-title":"EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications","volume":"12","author":"Li","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2022.154170_bib20","first-page":"731","article-title":"DNMT1 Is Predictive of Survival and Associated with Ki-67 Expression in R-CHOP-Treated Diffuse Large B-Cell Lymphomas","volume":"49","author":"Loo","year":"2017","journal-title":"Pathol. (Phila. )"},{"key":"10.1016\/j.prp.2022.154170_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.prp.2017.10.005","article-title":"DNMT1 is associated with cell cycle and DNA replication gene sets in diffuse large B-Cell Lymphoma","volume":"214","author":"Loo","year":"2018","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2022.154170_bib22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5483\/BMBRep.2019.52.5.055","article-title":"Enhanced anticancer effects of a methylation inhibitor by inhibiting a novel DNMT1 target, CEP 131, in cervical cancer","volume":"52","author":"Kim","year":"2019","journal-title":"BMB Rep."},{"key":"10.1016\/j.prp.2022.154170_bib23","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.18632\/oncotarget.14226","article-title":"Epigenetic therapy in urologic cancers: an update on clinical trials","volume":"8","author":"Faleiro","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2022.154170_bib24","first-page":"3971259","article-title":"of the Association between DNMT1 Polymorphisms and Cancer Risk","volume":"2017","author":"Li","year":"2017","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.prp.2022.154170_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.prp.2022.154170_bib26","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/cncr.22087","article-title":"Elevated MRNA Levels of DNA Methyltransferase-1 as an Independent Prognostic Factor in Primary Nonsmall Cell Lung Cancer","volume":"107","author":"Kim","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2022.154170_bib27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ijc.11127","article-title":"Increased protein expression of DNA methyltransferase (DNMT) 1 Is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas","volume":"105","author":"Saito","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2022.154170_bib28","first-page":"116","article-title":"Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma","volume":"14","author":"Zhang","year":"2012","journal-title":"Clin. Transl. Oncol. . Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mex."},{"key":"10.1016\/j.prp.2022.154170_bib29","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/s41467-018-04019-9","article-title":"Methylated DNMT1 and E2F1 are targeted for proteolysis by L3MBTL3 and CRL4DCAF5 ubiquitin ligase","volume":"9","author":"Leng","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.prp.2022.154170_bib30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.emboj.7601977","article-title":"Messenger RNA regulation: to translate or to degrade","volume":"27","author":"Shyu","year":"2008","journal-title":"EMBO J."},{"issue":"18","key":"10.1016\/j.prp.2022.154170_bib31","doi-asserted-by":"crossref","first-page":"18302","DOI":"10.1074\/jbc.M501675200","article-title":"Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer","volume":"280","author":"Agoston","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2022.154170_bib32","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1111\/j.1432-1033.2004.04271.x","article-title":"Cdt1 and geminin are down-regulated upon cell cycle exit and are over-expressed in cancer-derived cell lines","volume":"271","author":"Xouri","year":"2004","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.prp.2022.154170_bib33","doi-asserted-by":"crossref","first-page":"44905","DOI":"10.1074\/jbc.M105406200","article-title":"The human licensing factor for DNA replication Cdt1 accumulates in G1 and is destabilized after initiation of S-phase","volume":"276","author":"Nishitani","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2022.154170_bib34","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.acthis.2016.05.002","article-title":"Ki67, PCNA, and MCM proteins: markers of proliferation in the diagnosis of breast cancer","volume":"118","author":"Jur\u00edkov\u00e1","year":"2016","journal-title":"Acta Histochem"},{"key":"10.1016\/j.prp.2022.154170_bib35","first-page":"5762","article-title":"Long non-coding RNA AK027294 promotes tumor growth by upregulating PCNA in gastric cancer","volume":"23","author":"He","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.prp.2022.154170_bib36","first-page":"2436","article-title":"Re-replication induced by geminin depletion occurs from G2 and is enhanced by checkpoint activation","volume":"125","author":"Klotz-Noack","year":"2012","journal-title":"J. Cell. Sci."},{"issue":"30","key":"10.1016\/j.prp.2022.154170_bib37","doi-asserted-by":"crossref","first-page":"E2848","DOI":"10.1073\/pnas.1310677110","article-title":"Geminin deploys multiple mechanisms to regulate Cdt1 before cell division thus ensuring the proper execution of DNA replication","volume":"110","author":"Ballabeni","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822004149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822004149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:55:43Z","timestamp":1759733743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822004149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":37,"alternative-id":["S0344033822004149"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.154170","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different expression of DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN and EP300 genes in lymphomagenesis of low vs. high grade lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.154170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154170"}}